Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Petco
WOOF
$797M
| $11.4M | ﹤0.01% |
509,905
+166,305
| +48% | +$3.89M |
|
1927
CTS Corp
CTS
$1.83B
| $11.4M | ﹤0.01% |
305,825
+4,787
| +2% | +$165K |
|
|
SILK
1928
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $11.3M | ﹤0.01% |
236,480
+17,660
| +8% | +$900K |
|
|
LMNX
1929
DELISTED
Luminex Corp
LMNX
| $11.3M | ﹤0.01% |
307,465
-21,928
| -7% | -$797K |
|
1930
AMERISAFE
AMSF
$543M
| $11.3M | ﹤0.01% |
188,765
+9,857
| +6% | +$626K |
|
1931
Vroom Inc
VRM
$39M
| $11.3M | ﹤0.01% |
3,364
+95
| +3% | +$323K |
|
1932
Revolution Medicines
RVMD
$39.9B
| $11.3M | ﹤0.01% |
354,942
+40,136
| +13% | +$1.4M |
|
|
TPIC
1933
DELISTED
TPI Composites
TPIC
| $11.3M | ﹤0.01% |
232,606
+15,129
| +7% | +$744K |
|
1934
CNA Financial
CNA
$14.2B
| $11.2M | ﹤0.01% |
246,739
+7,532
| +3% | +$353K |
|
1935
US Physical Therapy
USPH
$1.2B
| $11.2M | ﹤0.01% |
96,431
+6,366
| +7% | +$731K |
|
1936
Constellium
CSTM
$3.76B
| $11.2M | ﹤0.01% |
589,232
+261,066
| +80% | +$4.5M |
|
|
DNMR
1937
DELISTED
Danimer Scientific, Inc.
DNMR
| $11.1M | ﹤0.01% |
11,094
+3,863
| +53% | +$3.85M |
|
1938
E.W. Scripps
SSP
$257M
| $11.1M | ﹤0.01% |
544,729
-6,616
| -1% | -$139K |
|
1939
Pathward Financial
CASH
$1.86B
| $11.1M | ﹤0.01% |
219,249
+2,175
| +1% | +$108K |
|
1940
SiTime
SITM
$16B
| $11.1M | ﹤0.01% |
87,564
+4,342
| +5% | +$444K |
|
1941
Levi Strauss
LEVI
$9.44B
| $11.1M | ﹤0.01% |
399,479
+37,357
| +10% | +$1.03M |
|
|
CVGW
1942
DELISTED
Calavo Growers
CVGW
| $11.1M | ﹤0.01% |
174,487
+10,803
| +7% | +$793K |
|
1943
Ameresco
AMRC
$1.12B
| $11.1M | ﹤0.01% |
176,384
+24,294
| +16% | +$1.31M |
|
|
GCP
1944
DELISTED
GCP Applied Technologies Inc.
GCP
| $11M | ﹤0.01% |
474,106
+2,205
| +0.5% | +$54.7K |
|
1945
Nabors Industries
NBR
$1.27B
| $11M | ﹤0.01% |
96,393
-12,070
| -11% | -$1.21M |
|
1946
PetMed Express
PETS
$41.7M
| $11M | ﹤0.01% |
345,391
+49,012
| +17% | +$1.56M |
|
1947
Schneider National
SNDR
$6.26B
| $11M | ﹤0.01% |
504,553
+43,997
| +10% | +$1.06M |
|
|
NXGN
1948
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $10.9M | ﹤0.01% |
659,637
+119,805
| +22% | +$2.15M |
|
1949
Haverty Furniture Companies
HVT
$397M
| $10.9M | ﹤0.01% |
255,914
+12,925
| +5% | +$565K |
|
|
RAD
1950
DELISTED
Rite Aid Corporation
RAD
| $10.9M | ﹤0.01% |
671,075
-4,094
| -0.6% | -$78.4K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.